CHARLOTTE, N.C.; Oct. 26, 2023 (Business Wire) — Catawba Research, a leading clinical research organization with a goal to become the world’s most trusted CRO, is announcing changes to its executive leadership team. Effective today, Catawba’s Founder, Zaidoon A. Al-Zubaidy, is transitioning his day-to-day leadership responsibilities to Dr. Andy Silverman. Al-Zubaidy will become executive chairman […]
CHARLOTTE, N.C.; March 30, 2023 – Catawba Research, a full-service contract research organization (CRO) for innovative trial management, is delighted to announce Andy Silverman, Ph.D., has joined its leadership team as its chief operating officer (COO). Dr. Silverman joins a leadership team with more than 100 years of clinical research experience and an expansive and […]
Check Out Our New Headquarters Catawba Research launched seven years ago. As we set out to build a world-class, full-service contract research organization, our journey quickly led us to many wonderful milestones. These accomplishments include dozens of agency approvals, a site network, and a rapidly-expanding presence around the globe. Now, we’re proud to unveil the […]
Catawba Research President and CEO Zaidoon A. Al-Zubaidy recently announced that the global CRO will relocate its home office operations to a larger space in the Charlotte, N.C. area. The news comes as the organization continues to grow in size, taking on Sponsors from around the world. Watch the press video now to learn more!
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, and government and public health organisations, today announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc. (NASDAQ: PRAH) in a cash and stock transaction valued at […]
“This acquisition is an integral part of Altasciences’ strategic growth plan to provide a comprehensive, fully integrated early phase drug development solution to address the ever-changing outsourcing challenges of biopharmaceutical companies across the globe. We look forward to working side by side with our new team of clinical experts in California, a team that shares […]
St. Cloud Capital is pleased to announce an investment in Charlotte, North Carolina-based Catawba Research. St. Cloud has partnered with a financial investment firm focused on control investments in the life sciences and industrial sectors to support Catawba's next phase of growth. It is an investment out of St. Cloud's third fund, which has committed capital […]
Catawba Research is proud to have served as the CRO for Vyome Therapeutics on their successful Phase 2 Trial of VB-1953 for Moderate to Severe Acne. Needless to say, Catawba Research is excited for our client and honored to be by their side. Vyome Therapeutics is a clinical-stage company developing locally-acting, next generation therapeutics for […]
Catawba Research is heading to Washington, D.C. March 1–3 to attend the American Academy of Dermatology (AAD) 2019 Annual Meeting. During our visit, we will be huddling up with site networks, sponsors, and others to discuss their CRO needs in the year ahead and beyond. With more than 26 studies completed in the last five […]
Here is a sample of our latest training video on plaque psoriasis with Dr. Zoe Draelos, a leader in clinical and research dermatology. To learn more about our training program or see some our videos, contact us!
